| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.1 |